Vitreomacular Traction in Diabetic Retinopathy

Overview

Journal Jpn J Ophthalmol

Specialty Ophthalmology

Date 2023 Nov 24

PMID 38001367

Authors

Yi-Ting Hsieh

Chung-May Yang

Affiliations

Soon will be listed here.

Abstract

Purpose: Vitreomacular traction (VMT) has unique presentations in eyes with diabetic retinopathy (DR). This study aimed to investigate the characteristics and clinical course of VMT in DR.

Study Design: A retrospective case series.

Methods: Thirty eyes from 30 patients with DR and concurrent VMT were retrospectively enrolled. Baseline and final best-corrected visual acuity (BCVA) and optical coherence tomography (OCT) characteristics were reported. Linear regression models were used to analyze the correlating factors for visual outcome.

Results: Of the 30 eyes, a thickened posterior hyaloid membrane was noted in all cases and multi-layered traction from different directions in 14 eyes (46.7%). Twenty-one eyes (70%) had tractional macular retinoschisis, seven (23.3%) had foveal detachment, five (16.7%) had a lamellar macular hole, and three (10%) had a full-thickness macular hole, including two with macular hole retinal detachment. Three eyes had spontaneous release of the VMT within 3 months of observation. For the remaining 27 eyes receiving operations, the VMT, full-thickness macular hole, and serous foveal detachment all resolved postoperatively with residual macular schisis in 6 eyes (22.2%) only. None of the baseline OCT characteristics were associated with postoperative BCVA (P > .05).

Conclusions: VMT in DR had a thickened posterior hyaloid, and many of them had multi-layered traction and/or concurrent macular retinoschisis. Lamellar macular hole, full-thickness macular hole, or concurrent retinal detachment may also occur. Spontaneous resolution of VMT rarely occurred, and those who underwent operation for VMT had improved vision and macular structures with resolution of the macular hole and retinal detachment.

Citing Articles

[Vitreomacular traction: diagnostics, natural course, treatment decision and guideline recommendations].

Faatz H, Hattenbach L, Krohne T, Priglinger S, Lommatzsch A Ophthalmologie. 2024; 121(6):470-475.

PMID: 38809382 DOI: 10.1007/s00347-024-02042-4.

References

Kampik A, Kenyon K, Michels R, Green W, De La Cruz Z . Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol. 1981; 99(8):1445-54. DOI: 10.1001/archopht.1981.03930020319025. View

K Muqit M, Stanga P . Swept-source optical coherence tomography imaging of the cortical vitreous and the vitreoretinal interface in proliferative diabetic retinopathy: assessment of vitreoschisis, neovascularisation and the internal limiting membrane. Br J Ophthalmol. 2014; 98(7):994-7. DOI: 10.1136/bjophthalmol-2013-304452. View

Su C, Yang C, Yeh P, Yang C . Macular tractional retinoschisis in proliferative diabetic retinopathy: clinical characteristics and surgical outcome. Ophthalmologica. 2013; 231(1):23-30. DOI: 10.1159/000355078. View

Ogura Y, Shiraga F, Terasaki H, Ohji M, Ishida S, Sakamoto T . Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists. Jpn J Ophthalmol. 2016; 61(1):43-50. DOI: 10.1007/s10384-016-0481-x. View

Cheema R, Mushtaq J, Al-Khars W, Al-Askar E, Cheema M . Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage. Retina. 2010; 30(10):1646-50. DOI: 10.1097/IAE.0b013e3181d6def0. View

Haines N, Manoharan N, Olson J, DAlessandro A, Reisz J . Metabolomics Analysis of Human Vitreous in Diabetic Retinopathy and Rhegmatogenous Retinal Detachment. J Proteome Res. 2018; 17(7):2421-2427. DOI: 10.1021/acs.jproteome.8b00169. View

Liew G, Lei Z, Tan G, Joachim N, Ho I, Wong T . Metabolomics of Diabetic Retinopathy. Curr Diab Rep. 2017; 17(11):102. DOI: 10.1007/s11892-017-0939-3. View

Rezzola S, Corsini M, Chiodelli P, Cancarini A, Nawaz I, Coltrini D . Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy. Diabetologia. 2017; 60(4):719-728. DOI: 10.1007/s00125-016-4204-0. View

Walia S, Clermont A, Gao B, Aiello L, Feener E . Vitreous proteomics and diabetic retinopathy. Semin Ophthalmol. 2010; 25(5-6):289-94. PMC: 4996366. DOI: 10.3109/08820538.2010.518912. View

10.

Klaassen I, van Geest R, Kuiper E, van Noorden C, Schlingemann R . The role of CTGF in diabetic retinopathy. Exp Eye Res. 2015; 133:37-48. DOI: 10.1016/j.exer.2014.10.016. View

11.

Deguine V, Menasche M, Ferrari P, Fraisse L, Pouliquen Y, Robert L . Free radical depolymerization of hyaluronan by Maillard reaction products: role in liquefaction of aging vitreous. Int J Biol Macromol. 1998; 22(1):17-22. DOI: 10.1016/s0141-8130(97)00084-6. View

12.

FOOS R, Kreiger A, Forsythe A, Zakka K . Posterior vitreous detachment in diabetic subjects. Ophthalmology. 1980; 87(2):122-8. DOI: 10.1016/s0161-6420(80)35269-x. View

13.

Katsumura C, Sugiyama T, Nakamura K, Obayashi H, Hasegawa G, Oku H . Effects of advanced glycation end products on hyaluronan photolysis: a new mechanism of diabetic vitreopathy. Ophthalmic Res. 2005; 36(6):327-31. DOI: 10.1159/000081635. View

14.

Lee E, Lee S, Lee J, Heo J, Yu H, Chung H . Anatomical configurations of vitreomacular traction syndrome: influence on clinical course and surgical outcomes. Graefes Arch Clin Exp Ophthalmol. 2019; 257(8):1631-1639. DOI: 10.1007/s00417-019-04352-9. View

15.

Wu L, Zas M, Berrocal M, Fernando Arevalo J, Figueroa M, Rodriguez F . ANATOMICAL AND FUNCTIONAL OUTCOMES OF SYMPTOMATIC IDIOPATHIC VITREOMACULAR TRACTION: A Natural History Study From the Pan American Collaborative Retina Study Group. Retina. 2016; 36(10):1913-8. DOI: 10.1097/IAE.0000000000001015. View

16.

Ljubimov A, Burgeson R, Butkowski R, Couchman J, Zardi L, Ninomiya Y . Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem. 1996; 44(12):1469-79. DOI: 10.1177/44.12.8985139. View

17.

George B, Chen S, Chaudhary V, Gonder J, Chakrabarti S . Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy. Curr Eye Res. 2009; 34(2):134-44. DOI: 10.1080/02713680802585946. View

18.

Hayashi K, Sato T, Manabe S, Hirata A, Yoshimura K . Posterior vitreous detachment in patients with diabetes mellitus. Jpn J Ophthalmol. 2020; 64(2):187-195. DOI: 10.1007/s10384-020-00720-9. View

19.

Frisina R, Pilotto E, Midena E . Lamellar Macular Hole: State of the Art. Ophthalmic Res. 2019; 61(2):73-82. DOI: 10.1159/000494687. View

20.

Kuo B, Yang C, Hsieh Y . Lamellar macular hole in diabetic retinopathy. Eur J Ophthalmol. 2019; 31(1):166-172. DOI: 10.1177/1120672119879665. View